BiomX cancels 1.01M shares to comply with NYSE American stockholder approval rule

BiomX Inc.

• 1,013,637 restricted shares issued on June 2, 2026 upon conversion of $379,000 promissory note under a line of credit.
• NYSE American determined the acquisition and line of credit are related transactions requiring shareholder approval under Section 712.
• All 1,013,637 shares were cancelled on July 10, 2026 and returned to treasury to regain compliance.
• Company will seek stockholder approval at a future meeting; no assurance of obtaining approval.
• Failure to obtain approval could lead to further NYSE American action regarding listing of PHGE common stock.